Digital Pathology Podcast

Digital Pathology Podcast

Aleksandra Zuraw, DVM, PhD
Country USA
Language EN-US
Episodes 242
Latest 18.11.2026

Aleksandra Zuraw from Digital Pathology Place hosts this podcast that explores digital pathology from foundational concepts to cutting-edge developments, including image analysis and artificial intelligence. The show reviews scientific literature and features discussions with guests about current industry and research trends in digital pathology.

Episodes

  • 257: Digital Cytology and AI in Practice | CorePlus x Epredia at PathVisions 2026
    257: Digital Cytology and AI in Practice | CorePlus x Epredia at PathVisions 2026 18.11.2026 48m
    Send us Fan Mail Can a lab run cytology fully digital, with AI, and still keep rescans near 1%? CorePlus in Puerto Rico has been reading histology digitally since January 1, 2020. Then they took on the hard part: digital cytology. In this talk from the Epredia breakfast workshop at PathVisions 2026, CorePlus founder Mariano de Socarraz walks through six years of building one scanner platform for histology, Pap smears and low-cellularity urine cytology, and where AI paid off. Every AI proj...
  • 256: Digital Pathology 101, 2nd Edition: What Changed and Why | Free Book Launch
    256: Digital Pathology 101, 2nd Edition: What Changed and Why | Free Book Launch 16.11.2026 29m
    Send us Fan Mail What changes when tissue becomes data? A glass slide is a data point: one person, one place, one moment, then a box in the archive. A digital slide is a data source: it can be shared, measured, reused and revisited. That idea runs through the whole second edition of Digital Pathology 101, and in this live launch I walk you through what changed since the 2023 edition and why. I'm Dr. Aleks Zuraw, a board-certified veterinary and toxicologic pathologist and the host of the ...
  • 255: Are Robots the Next Big Shift in Digital Pathology | with Trang Vu, PhD
    255: Are Robots the Next Big Shift in Digital Pathology | with Trang Vu, PhD 05.11.2026 57m
    Send us Fan Mail Robots are reaching the pathology lab, whole slide scanners are back in the spotlight, and pathology AI companies are getting bought. Dr. Aleks Zuraw, board-certified veterinary pathologist and host of the Digital Pathology Podcast, recaps PathVisions 2026, the Digital Pathology Association's annual meeting, with Trang Vu, who comes from the spatial biology side and tracks digital pathology vendors closely. You'll learn: Why hardware and robotics took over the PathVisions e...
  • 254: Digital Pathology Q&A: How to Get Started | PathVisions 2026
    254: Digital Pathology Q&A: How to Get Started | PathVisions 2026 30.10.2026 41m
    Send us Fan Mail Is a digital slide as good as glass? Live from the Hamamatsu booth at PathVisions 2026, Dr. Aleks Zuraw and Amy Welch, Product Marketing Manager for NanoZoomer at Hamamatsu, open the question box and answer the beginner questions attendees dropped in all week. Elizabeth Blakely joins as a surprise guest. You'll learn: Whether a digital slide is as good as glass for diagnosisHow long it takes to scan a slide, and why the 15 x 15 mm benchmark means little to a pathologistHow a ...
  • 253: What Happens After Your Whole Slide Scanner Arrives? | PathVisions 2026
    253: What Happens After Your Whole Slide Scanner Arrives? | PathVisions 2026 27.10.2026 13m
    Send us Fan Mail What happens after your whole slide scanner arrives in the lab? Live from the Hamamatsu booth at PathVisions 2026, Dr. Aleks Zuraw meets the people who help labs go digital, plus a surprise guest from the DICOM standard. In this episode: David Clunie of DICOM Working Group 26 on the PathVisions 2026 DICOM Connectathon: scanners, archives, viewers and annotation tools from different vendors working together, and the new work on annotations with holesStephanie Fullerton introdu...
  • 252: Digital Pathology Trends 2026: Agilent Buys Proscia | PathVisions
    252: Digital Pathology Trends 2026: Agilent Buys Proscia | PathVisions 18.10.2026 13m
    Send us Fan Mail What are the biggest digital pathology trends of 2026, and what does Agilent buying Proscia tell us? It's the clearest sign yet that the field is moving from shiny algorithms to full, connected workflows. In this live recap from Pathology Visions 2026 in San Diego, Dr. Aleks Zuraw (DVM, PhD, DACVP), board-certified veterinary pathologist and host of the Digital Pathology Podcast, sits down with Imogen Fitt of Signify Research to break down the biggest news of the week and th...
  • 251: Pathology Foundation Models: PathBench, Scanner Shift, and the HER2 Slide Swing
    251: Pathology Foundation Models: PathBench, Scanner Shift, and the HER2 Slide Swing 15.10.2026 25m
    Send us Fan Mail What if changing the scanner or choosing another slide from the same tumor changes your pathology AI results? In DigiPath Digest #52, I review three studies on pathology foundation models, scanner shift, and slide selection to ask how much of “model performance” comes from the model itself. We look at a benchmark comparing 32 foundation models across 41 tasks, a study testing 10 models across scanners and centers, and a breast cancer study examining how predictions change whe...
  • 250: AI for Scientific Writing: 4 Rules from a Pathologist
    250: AI for Scientific Writing: 4 Rules from a Pathologist 08.10.2026 21m
    Send us Fan Mail Can you use AI to write scientific papers without fabricated references, journal trouble or learning to code? I recorded this episode at the airport on my way to ESTP 2026 in Kraków. It's my practice run of the talk I gave there. When deep learning came into pathology, people asked me if I was going to learn to code. I decided no. Large language models kind of proved me right. In this episode I walk you through how I use LLMs for writing papers, responding to co-authors, buil...
  • 249:  Cytopathology AI: Crowded-Cell Gaps and LLM Guardrails
    249: Cytopathology AI: Crowded-Cell Gaps and LLM Guardrails 31.08.2026 29m
    Send us Fan Mail What happens when AI models that perform almost perfectly on scattered cervical cells become less reliable than a coin flip on crowded cell groups? In DigiPath Digest #51, I examine what this performance gap tells us about artificial intelligence in cytopathology. The first paper evaluated six convolutional neural network models trained to distinguish benign from high-grade lesions using scattered cervical cytology cells. The models achieved AUCs ranging from 0.950 to 0.996 o...
  • 248:  Are Foundation Models Really Better for Digital Pathology? Podcast with Panu Kauppila
    248: Are Foundation Models Really Better for Digital Pathology? Podcast with Panu Kauppila 20.08.2026 51m
    Send us Fan Mail What good is a powerful foundation model if it slows the pathologist down, can’t explain its result, or doesn’t fit the clinical workflow? Foundation models are gaining attention across digital pathology. But they’re not finished clinical tools by themselves. In this episode of the Digital Pathology Podcast, I speak with Panu Kauppila, Chief Product Officer at Aiforia, about what foundation models are, how they differ from traditional convolutional neural networks, and what i...
  • 247:  Screening Efficiency Over Experience: Rethinking Cytology Expertise
    247: Screening Efficiency Over Experience: Rethinking Cytology Expertise 17.08.2026 27m
    Send us Fan Mail Does more experience automatically make a cytotechnologist more accurate—or does where they look first matter more? In DigiPath Digest #50, I review a digital cytology eye-tracking study that challenges the assumption that diagnostic accuracy improves steadily with years of practice. The researchers tracked the visual behavior of 100 board-certified cytotechnologists with 1 to 40 years of experience. They found no statistically significant linear relationship between years of...
  • 246:  Computational Pathology Is Changing Companion Diagnostics
    246: Computational Pathology Is Changing Companion Diagnostics 13.08.2026 1h 5m
    Send us Fan Mail Can a treatment decision depend on whether one pathologist sees 45% biomarker positivity and another sees 55%? Visual immunohistochemistry scoring helped establish precision oncology. But as targeted therapies become more sensitive to subtle biological differences, categorical scores such as 0, 1+, 2+, and 3+ may no longer capture the information needed to identify the right patients. In this episode, I speak with three Roche experts: Gordana Juric-Sekhar, MD, anatomic pathol...
  • 245:  Why Going Slow Is Killing Digital Pathology Adoption | Syed T. Hoda, M.D.
    245: Why Going Slow Is Killing Digital Pathology Adoption | Syed T. Hoda, M.D. 29.07.2026 43m
    Send us Fan Mail Is your digital pathology rollout moving so slowly that it’s creating a fragmented workflow instead of transforming the department? In this episode of the Digital Pathology Podcast, I speak with Dr. Syed Hoda, Director of Digital Pathology at NYU, about why gradual implementation may no longer be the best approach to digital pathology adoption. Dr. Hoda explains how NYU used an intensive nine-month planning period to prepare for a department-wide transition. The process invol...
  • 244: Why AI Still Hasn't Revolutionized Drug Discovery (Yet) | Thibault Geoui, PhD
    244: Why AI Still Hasn't Revolutionized Drug Discovery (Yet) | Thibault Geoui, PhD 22.07.2026 1h 35m
    Send us Fan Mail If AI is already being used across the drug development pipeline, why hasn’t its impact matched the investment? AI can help researchers review scientific literature, predict protein structures, prioritize molecules, assess toxicity, support clinical trials, and monitor adverse events. But access to better tools doesn’t automatically create better drugs. In this episode, I speak with Thibault Geoui, Science CDO and host of the Tech & Drugs Podcast, about where AI is making...
  • 243: How to Teach AI to Healthcare Professionals | Podcast with Candice Chu
    243: How to Teach AI to Healthcare Professionals | Podcast with Candice Chu 02.07.2026 42m
    Send us Fan Mail What does AI literacy actually look like for pathologists, researchers, and future clinicians? And how do you teach it in a way that is practical, not abstract? In this episode, I talk with Candice Chu, DVM, PhD about something I think a lot of people in digital pathology and computational pathology are feeling right now: AI is moving fast, but education is still catching up. Candice is a clinical pathologist, veterinarian, and educator building AI-focused teaching and r...
  • 242: Foundation Models in Pathology: Strong on Paper, Ready for Labs?
    242: Foundation Models in Pathology: Strong on Paper, Ready for Labs? 24.06.2026 42m
    Send us Fan Mail Are pathology foundation models actually ready for labs, or are they still stronger on paper than in practice? In this episode of DigiPath Digest #49, I unpack a timely review on pathology foundation models and ask the question that matters most to me: not just what these models can do, but what has to be true before they are genuinely useful in real pathology workflows. I walk through how pathology AI moved from narrow, task-specific models into the era of transformer-based ...
  • 241: AI-Powered Companion Diagnostics: The Future of Precision Medicine | Podcast with Doug Bowman, VP Precision Medicine at Indica Labs, Inc.
    241: AI-Powered Companion Diagnostics: The Future of Precision Medicine | Podcast with Doug Bowman, VP Precision Medicine at Indica Labs, Inc. 16.06.2026 41m
    Send us Fan Mail How far can pathologists take visual biomarker scoring before human vision becomes the bottleneck? In this episode, I talk with Doug Bowman. PhD, VP Precision Medicine at Indica Labs, about what happens when companion diagnostics move from traditional visual scoring into the era of AI-powered image analysis. Doug comes from a biomedical and electrical engineering background, with experience in microscopy, digital image analysis, pharma workflows, and now precision medicine at...
  • 240: Can AI Copilots Keep Up with Pathologists?
    240: Can AI Copilots Keep Up with Pathologists? 03.06.2026 33m
    Send us Fan Mail Can AI copilots really keep up with pathologists when the cases are new, the workflow is messy, and the benchmark is actually protected from leakage? In this episode of DigiPath Digest #48, I focus on one paper: DALPHIN: Benchmarking Digital Pathology AI Copilots Against Pathologists on an Open Multicentric Dataset. I chose this paper because I think the field needs more of this kind of work. Less hype. More evaluation. Less “look what AI can do.” More “how do we test it in a...
  • 239: The Four Steps Pathology AI Demos Quietly Skip and Why They Matter
    239: The Four Steps Pathology AI Demos Quietly Skip and Why They Matter 28.05.2026 47m
    Send us Fan Mail What happens when a pathology AI model misses the tissue before it even begins—and can better segmentation, education, and virtual staining close the gaps? In DigiPath Digest #47, I review four recent studies that expose both the promise and the weak points of AI-assisted digital pathology. We start with a step that sounds simple: detecting tissue on a whole slide image. Yet when that first step fails, the downstream algorithm may miss cancer entirely. From there, I look at a...
  • 238: How Do We Know AI Is Ready for Pathology
    238: How Do We Know AI Is Ready for Pathology 19.05.2026 20m
    Send us Fan Mail Do you really need a scanner, whole slide images, and AI infrastructure before you can start in digital pathology? In this episode, I argue that you do not. I’m Dr. Aleksandra Zuraw, veterinary pathologist and digital pathology educator, and this talk is about a belief I hear all the time: I don’t have the tools yet, so there is no point learning digital pathology. I used to think that too. When I was training in Berlin, there was one Leica 6-slide scanner, and it felt like d...

Popular in

The podcast also appears in the podcast charts of these countries.